Loading…
This event has ended. Visit the official site or create your own event on Sched.

SS

Sandra Suarez Sharp

FDA
Biopharmaceutics Lead (Acting), DB Branch III, ODNP, OPQ, CDER
Dr. Sandra Suarez-Sharp joined the Office of Clinical Pharmacology (OCP) at the FDA, in September 1999. Currently, she works at the Office of New Drug Products/Division of Biopharmaceutics (FDA/OPQ/ONDP) as a Master Biopharmaceutics Reviewer/Biopharmaceutics Lead (acting) supporting all therapeutic areas.

My Speakers Sessions

Monday, June 27
 

8:30am EDT

#115: Clinically Relevant Specifications: Translating Voice of the Patient Into Quality Attributes of the Product 111AB